All Stories

  1. Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity
  2. Poly-ε-Caprolactone Implants for Benznidazole Prolonged Release: An Alternative to Chagas Disease Oral Treatment
  3. Polyester Nanocapsules for Intravenous Delivery of Artemether: Formulation Development, Antimalarial Efficacy, and Cardioprotective Effects In Vivo
  4. Nanoformulations with Leishmania braziliensis Antigens Triggered Controlled Parasite Burden in Vaccinated Golden Hamster (Mesocricetus auratus) against Visceral Leishmaniasis
  5. PLA‐b‐SMA as an Amphiphilic Diblock Copolymer for Encapsulation of Lipophilic Cargo
  6. In vitro interaction of polyethylene glycol-block-poly(D,L-lactide) nanocapsule devices with host cardiomyoblasts and Trypanosoma cruzi-infective forms
  7. Photodynamic therapy with the dual-mode association of IR780 to PEG-PLA nanocapsules and the effects on human breast cancer cells
  8. Polylactide Nanocapsules Attenuate Adverse Cardiac Cellular Effects of Lyso-7, a Pan-PPAR Agonist/Anti-Inflammatory New Thiazolidinedione
  9. Higher oral efficacy of ravuconazole in self-nanoemulsifying systems in shorter treatment in experimental chagas disease
  10. Repositioning of Tamoxifen in Surface-Modified Nanocapsules as a Promising Oral Treatment for Visceral Leishmaniasis
  11. Release, transfer and partition of fluorescent dyes from polymeric nanocarriers to serum proteins monitored by asymmetric flow field-flow fractionation
  12. Review on Experimental Treatment Strategies Against Trypanosoma cruzi
  13. Lipid-based nanocarriers co-loaded with artemether and triglycerides of docosahexaenoic acid: Effects on human breast cancer cells
  14. Mechanistic insights into the intracellular release of doxorubicin from pH-sensitive liposomes
  15. PLA-PEG nanospheres decorated with phage display selected peptides as biomarkers for detection of human colorectal adenocarcinoma
  16. Mechanisms of artemether toxicity on single cardiomyocytes and protective effect of nanoencapsulation
  17. Labeling PLA-PEG nanocarriers with IR780: physical entrapment versus covalent attachment to polylactide
  18. Physical and biological effects of paclitaxel encapsulation on disteraroylphosphatidylethanolamine-polyethyleneglycol polymeric micelles
  19. Lychnopholide in Poly( d , l -Lactide)- Block -Polyethylene Glycol Nanocapsules Cures Infection with a Drug-Resistant Trypanosoma cruzi<...
  20. Cloxacillin nanostructured formulation for the treatment of bovine keratoconjunctivitis
  21. Benznidazole Self-Emulsifying Delivery System: A Novel Alternative Dosage Form For Chagas Disease Treatment
  22. Cloxacillin benzathine-loaded polymeric nanocapsules: Physicochemical characterization, cell uptake, and intramammary antimicrobial effect
  23. IR780-polymer conjugates for stable near-infrared labeling of biodegradable polyester-based nanocarriers
  24. Phthalocyanine photosensitizer in polyethylene glycol-block-poly(lactide-co-benzyl glycidyl ether) nanocarriers: Probing the contribution of aromatic donor-acceptor interactions in polymeric nanospheres
  25. Mechanisms of interaction of biodegradable polyester nanocapsules with non-phagocytic cells
  26. Paclitaxel-Loaded pH-Sensitive Liposome: New Insights on Structural and Physicochemical Characterization
  27. Relationship between virulence factor genes in coagulase-negative Staphylococcus spp. and failure of antimicrobial treatment of subclinical mastitis in sheep
  28. Biodistribution of free and encapsulated 99mTc-fluconazole in an infection model induced by Candida albicans
  29. Time and dose-dependence evaluation of nitroheterocyclic drugs for improving efficacy following Trypanosoma cruzi infection: A pre-clinical study
  30. Reduced cardiotoxicity and increased oral efficacy of artemether polymeric nanocapsules in Plasmodium berghei-infected mice
  31. Increased Body Exposure to New Anti-Trypanosomal Through Nanoencapsulation
  32. Impact of dose and surface features on plasmatic and liver concentrations of biodegradable polymeric nanocapsules
  33. Ravuconazole self-emulsifying delivery system
  34. Functional polylactide via ring-opening copolymerisation with allyl, benzyl and propargyl glycidyl ethers
  35. Biodegradable Polymeric Nanocapsules Prevent Cardiotoxicity of Anti-Trypanosomal Lychnopholide
  36. Uso de antimicrobiano nanoparticulado para o tratamento da mastite subclínica de ovelhas de corte no período seco
  37. Efficacy of Lychnopholide Polymeric Nanocapsules after Oral and Intravenous Administration in Murine Experimental Chagas Disease
  38. Polymeric nanocapsules prevent oxidation of core-loaded molecules: evidence based on the effects of docosahexaenoic acid and neuroprostane on breast cancer cells proliferation
  39. Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation
  40. Characterization and in vivo evaluation of nanocapsules loading 99mTc-MIBI for intramammary study
  41. Improvement of pharmacokinetic profile and efficacy of sesquiterpene lactone in nanocarriers in the experimental Chagas disease in mice
  42. Therapeutical approaches under investigation for treatment of Chagas disease
  43. In vivoantimalarial efficacy of acetogenins, alkaloids and flavonoids enriched fractions fromAnnona crassifloraMart.
  44. Sesquiterpene Lactone in Nanostructured Parenteral Dosage Form Is Efficacious in Experimental Chagas Disease
  45. Chloroaluminium phthalocyanine polymeric nanoparticles as photosensitisers: Photophysical and physicochemical characterisation, release and phototoxicity in vitro
  46. HPLC-DAD and UV-Spectrophotometry for the Determination of Lychnopholide in Nanocapsule Dosage Form: Validation and Application to Release Kinetic Study
  47. HPLC-FLD methods to quantify chloroaluminum phthalocyanine in nanoparticles, plasma and tissue: application in pharmacokinetic and biodistribution studies
  48. Profile of wound healing process induced by allantoin
  49. Nanotechnology applied to the treatment of malaria
  50. Biodistribution study and identification of inflammatory sites using nanocapsules labeled with 99mTc–HMPAO
  51. Release profiles and morphological characterization by atomic force microscopy and photon correlation spectroscopy of 99mTechnetium-fluconazole nanocapsules
  52. PLA-PEG nanocapsules radiolabeled with 99mTechnetium-HMPAO: Release properties and physicochemical characterization by atomic force microscopy and photon correlation spectroscopy
  53. Nanotecnologia farmacêutica aplicada ao tratamento da malária
  54. Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices
  55. Surface-Modified and Conventional Nanocapsules as Novel Formulations for Parenteral Delivery of Halofantrine
  56. Poly-Caprolactone Nanocapsules Morphological Features by Atomic Force Microscopy
  57. Polymeric Nanostructures for Drug Delivery: Characterization by Atomic Force Microscopy
  58. Efficacy and Pharmacokinetics of Intravenous Nanocapsule Formulations of Halofantrine in Plasmodium berghei-Infected Mice
  59. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules
  60. The antileishmanial properties of surface-modified, primaquine-loaded nanocapsules tested against intramacrophagic Leishmania donovani amastigotes in vitro
  61. A comparative study of the cellular uptake, localization and phototoxicity of meta-tetra(hydroxyphenyl) chlorin encapsulated in surface-modified submicronic oil/water carriers in HT29 tumor cells
  62. Poly(D,L‐Lactide) Nanocapsules Prepared by a Solvent Displacement Process: Influence of the Composition on Physicochemical and Structural Properties
  63. Interactions between a Macrophage Cell Line (J774A1) and Surface-modified Poly(D,L-lactide) Nanocapsules Bearing Poly(ethylene glycol)